Nasal swab nucleic acid amplification tests (NAATs) are “a type of viral diagnostic test for SARS-CoV-2, the virus that causes COVID-19.” [https://www.cdc.gov/coronavirus/2019-ncov/lab/naats.html and https://www.fda.gov/consumers/consumer-updates/covid-19-test-basics] Although certain NAAT tests have now been authorized for emergency use (EUA) for screening purposes (in asymptomatic persons), the three NAAT tests used at the time […]
Report 60: 449 Patients Suffer Bell’s Palsy Following Pfizer mRNA COVID Vaccination in Initial Three Months of Rollout. A One-Year-Old Endured Bell’s Palsy After Unauthorized Injection.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Joseph Gehrett, MD; Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt – produced a disturbing review of the Facial Paralysis System Organ Class (SOC) adverse events found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse […]
Report 52: Nine Months Post-COVID mRNA “Vaccine” Rollout, Substantial Birth Rate Drops in 13 European Countries, England/Wales, Australia, and Taiwan.
Robert W. Chandler, MD, completed extensive research to write the article below. Some of the highlights of this important piece include: Nine months following the rollout of the COVID-19 mRNA “vaccines,” substantial birth rate drops were seen in 13 of 19 European countries, England and Wales (one entity based on how […]
Pfizer/BioNTech Trial – A failed yet in depth attempt to reproduce the NEJM & FDA efficacy figures
Study version 1.3, published on 2022-12-09 To view the full version with graphics, please click here. Introduction We review, in this article, a list of problems in the Pfizer/BioNTech C4591001 Trial, which came out in our attempts to reproduce the results provided by the study. Using the sponsor’s data communicated to […]
“170 Patients That Changed Everything” – Spectator | Australia
Few people realise that the Emergency Use Authorisation (EUA) of the Pfizer-BioNTech Covid-19 Vaccine/BNT162b2 was granted on the efficacy data of 170 patients. The 162 who received a placebo and 8 patients who were vaccinated formed the basis of the 95 per cent efficacy claims. There has not been much […]